DoW Peer Reviewed Medical, Impact Award
About
Summary: The fiscal year 2026 (FY26) Peer Reviewed Medical Research Program (PRMRP) Impact Award supports applied research, defined as use-inspired and practice-oriented science that brings together outcomes from basic research, and insights from the real-world environment, to foster clinical applicability. The Impact Award intends to translate the fundamental understanding of underlying mechanisms toward solutions that have the potential for major near-term impact for patients and clear alignment to one of the congressionally directed FY26 PRMRP topic areas and one of the FY26 PRMRP portfolio-specific strategic goals. Distinctive Features: This funding mechanism allows for multiple Principal Investigators (PIs). Only the initiating PI’s organization will submit a pre-application, but all PIs’ organizations will need to submit full applications. The partnering PI’s application is an abbreviated package specific to their distinct portion of the research project. Be advised, all associated applications for a research project may be withdrawn if the initiating or partnering application is rejected or administratively withdrawn. Funding Details: The Congressionally Directed Medical Research Programs (CDMRP) expects to allot roughly $32.0M to fund approximately 10 Impact Award applications with total cost caps of $2.8M for the Single PI Option, or $3.6M for the Partnering PI Option. The maximum period of performance is 4 years. It is anticipated that awards made from this FY26 fun.
The DoW Peer Reviewed Medical Impact Award is a prestigious federal grant program administered by the Congressionally Directed Medical Research Programs (CDMRP) designed to support applied medical research with significant near-term clinical potential. This grant is ideal for medical researchers, academic institutions, and research organizations seeking to translate fundamental scientific discoveries into practical solutions that directly benefit patients. The program emphasizes use-inspired, practice-oriented science that bridges basic research with real-world clinical applications. Researchers can apply as a single PI or establish partnerships across multiple organizations, with the lead organization submitting the pre-application. The Impact Award is particularly valuable for teams working on congressionally prioritized FY26 PRMRP topic areas and those aligned with specific portfolio strategic goals. With approximately $32.0M available for roughly 10 awards, this competitive program offers substantial funding for research teams ready to demonstrate how their work will achieve major clinical impact within a reasonable timeframe. Entrepreneurs and researchers in the medical research space should apply if they have innovative, translational research that connects laboratory discoveries to patient outcomes and addresses current research priorities.
Funding Facts
● Applications openDeadline
August 6, 2026
Who can apply
Last verified July 5, 2026 · Source: Grants.gov
Grant Details
Funding Range
$2.8M - $3.6M per award
Deadline
2026-08-06
Grant Type
federal
Application Cycle
Annual (FY26 cycle with August 2026 deadline)
Best For
Medical researchers, academic institutions, and research organizations with applied, translational medical research aligned to congressionally prioritized topics
Frequently Asked Questions
Who is eligible for DoW Peer Reviewed Medical Impact Award?
The program supports applied medical research teams with single or multiple Principal Investigators (PIs). Specific eligibility criteria are not detailed in the available information. For complete eligibility requirements, including organizational type, researcher qualifications, and any geographic or institutional restrictions, please visit the official CDMRP website or contact the program administrator directly.
How much funding does DoW Peer Reviewed Medical Impact Award provide?
The CDMRP expects to allocate approximately $32.0 million to fund roughly 10 Impact Award applications. Individual award amounts have a total cost cap of $2.8 million for the Single PI Option or $3.6 million for the Partnering PI Option. The maximum period of performance is 4 years.
How do I apply for DoW Peer Reviewed Medical Impact Award?
The application process involves a pre-application stage followed by full applications. The initiating PI's organization submits the pre-application, while all partnering PIs' organizations submit abbreviated full applications specific to their research portion. Please note that all associated applications may be withdrawn if the initiating or any partnering application is rejected. For detailed submission instructions, timelines, and application portal access, visit the official CDMRP website.
What can DoW Peer Reviewed Medical Impact Award funding be used for?
This grant funds applied research that is use-inspired and practice-oriented, translating fundamental research discoveries toward clinical solutions with major near-term patient impact. Research must align with one of the congressionally directed FY26 PRMRP topic areas and one of the FY26 PRMRP portfolio-specific strategic goals. Projects should demonstrate clear pathways from laboratory findings to real-world clinical applications.
Last updated: July 5, 2026